{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:49:48Z","timestamp":1791506988285,"version":"4.3.4"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274212"],"award-info":[{"award-number":["82274212"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08648-3","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T04:05:42Z","timestamp":1784001942000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hepatic FXR deficiency exacerbates dyslipidemia by disrupting the gut-liver axis via bile acid disorder and gut microbiota dysbiosis"],"prefix":"10.1186","volume":"24","author":[{"given":"Yunlu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenchen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinglan","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8944-4174","authenticated-orcid":false,"given":"Ya","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"issue":"8","key":"8648_CR1","first-page":"2024","volume":"5","author":"X Shen","year":"2020","unstructured":"Shen X, Yang H, Yang Y, Zhu X, Sun Q. The cellular and molecular targets of natural products against metabolic disorders: a translational approach to reach the bedside. Medcomm. 2020;5(8):2024\u2013e664.","journal-title":"Medcomm"},{"issue":"Suppl","key":"8648_CR2","doi-asserted-by":"publisher","first-page":"s86","DOI":"10.3350\/cmh.2022.0442","volume":"29","author":"R Manikat","year":"2023","unstructured":"Manikat R, Nguyen MH. Nonalcoholic fatty liver disease and non-liver comorbidities. Clin Mol Hepatol. 2023;29(Suppl):s86\u2013102.","journal-title":"Clin Mol Hepatol"},{"issue":"10","key":"8648_CR3","first-page":"689","volume":"18","author":"A Pirillo","year":"2021","unstructured":"Pirillo A, Casula M, Olmastroni E, Norata GD, Catapano AL. Global epidemiology of dyslipidaemias, Nature Reviews. Cardiology. 2021;18(10):689\u2013700.","journal-title":"Cardiology"},{"issue":"11","key":"8648_CR4","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1038\/s41591-025-03931-0","volume":"31","author":"N Chami","year":"2025","unstructured":"Chami N, Wang Z, Svenstrup V, Obrero VD, Hemerich D, Huang Y, Dashti H, Manitta E, Preuss MH, North KE, Holm LA, Fonvig CE, Holm J, Hansen T, Scheele C, Rauch A, Smit RAJ, Claussnitzer M, Loos RJF. Genetic subtyping of obesity reveals biological insights into the uncoupling of adiposity from its cardiometabolic comorbidities. Nat Med. 2025;31(11):3801\u201312.","journal-title":"Nat Med"},{"issue":"7810","key":"8648_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41586-020-2338-1","volume":"582","author":"RFCN Ncd","year":"2020","unstructured":"Ncd RFCN. Repositioning of the global epicentre of non-optimal cholesterol. Nature. 2020;582(7810):73\u20137.","journal-title":"Nature"},{"issue":"1","key":"8648_CR6","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s10020-024-01014-3","volume":"30","author":"N Shi","year":"2024","unstructured":"Shi N, Jiang S, Zhao Y, Zhang Y, Duan X, Hong G, Yang Z, Duan Y, Niu H. Hfd aggravated the arthritis and atherosclerosis by altering the intestinal status and gut microbiota. Mol Med (Cambridge Mass). 2024;30(1):270.","journal-title":"Mol Med (Cambridge Mass)"},{"issue":"1","key":"8648_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41392-025-02329-1","volume":"11","author":"H Che","year":"2026","unstructured":"Che H, Gao Y, Xu Y, Xu H, Eils R, Tian M. Organ cross-talk: molecular mechanisms, biological functions, and therapeutic interventions for diseases. Signal Transduct Target Ther. 2026;11(1):8.","journal-title":"Signal Transduct Target Ther"},{"key":"8648_CR8","doi-asserted-by":"publisher","first-page":"107694","DOI":"10.1016\/j.phrs.2025.107694","volume":"214","author":"M You","year":"2025","unstructured":"You M, Zhou L, Wu F, Zhang L, Zhu S, Zhang H. Probiotics for the treatment of hyperlipidemia: focus on gut-liver axis and lipid metabolism. Pharmacol Res. 2025;214:107694.","journal-title":"Pharmacol Res"},{"key":"8648_CR9","doi-asserted-by":"crossref","unstructured":"He Y, Shaoyong W, Chen Y, Li M, Gan Y, Sun L et al. The functions of gut microbiota-mediated bile acid metabolism in intestinal immunity. J Adv Res. 2026;80:351\u201370.","DOI":"10.1016\/j.jare.2025.05.015"},{"issue":"10","key":"8648_CR10","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1016\/j.cmet.2023.07.011","volume":"35","author":"J Kuang","year":"2023","unstructured":"Kuang J, Wang J, Li Y, Li M, Zhao M, Ge K, Zheng D, Cheung KCP, Liao B, Wang S, Chen T, Zhang Y, Wang C, Ji G, Chen P, Zhou H, Xie C, Zhao A, Jia W, Zheng X, Jia W. Hyodeoxycholic acid alleviates non-alcoholic fatty liver disease through modulating the gut-liver axis. Cell Metab. 2023;35(10):1752\u201366.","journal-title":"Cell Metab"},{"issue":"2","key":"8648_CR11","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1152\/physrev.00049.2019","volume":"101","author":"A Perino","year":"2021","unstructured":"Perino A, Demagny H, Velazquez-Villegas L, Schoonjans K. Molecular physiology of bile acid signaling in health, disease, and aging. Physiol Rev. 2021;101(2):683\u2013731.","journal-title":"Physiol Rev"},{"issue":"2","key":"8648_CR12","doi-asserted-by":"publisher","first-page":"4725","DOI":"10.1097\/JS9.0000000000003851","volume":"112","author":"A Ramesh","year":"2026","unstructured":"Ramesh A, Subbarayan R, Srinivasan D, Balakrishnan R, Shrestha R, Chauhan A. Gut microbiota-mediated oncogenesis in hepatocellular carcinoma: a new avenue for therapeutic intervention. Int J Surg (London England). 2026;112(2):4725\u201350.","journal-title":"Int J Surg (London England)"},{"issue":"5","key":"8648_CR13","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41575-020-00404-2","volume":"18","author":"L Sun","year":"2021","unstructured":"Sun L, Cai J, Gonzalez FJ. The role of farnesoid x receptor in metabolic diseases, and gastrointestinal and liver cancer. Nat Rev Gastroenterol Hepatol. 2021;18(5):335\u201347.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"9","key":"8648_CR14","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1038\/s42255-021-00452-1","volume":"3","author":"KM Schneider","year":"2021","unstructured":"Schneider KM, Candels LS, Hov JR, Myllys M, Hassan R, Schneider CV, Wahlstr A, Mohs MA, Z\u00fchlke S, Liao L, Elfers C, Kilic K, Henricsson M, Molinaro A, Hatting M, Zaza A, Drasdo D, Frissen M, Devlin AS, G\u00e1lvez EJC, Strowig T, Karlsen TH, Hengstler JG, Marschall H, Ghallab A, Trautwein C. Gut microbiota depletion exacerbates cholestatic liver injury via loss of fxr signalling. Nat Metab. 2021;3(9):1228\u201341.","journal-title":"Nat Metab"},{"key":"8648_CR15","doi-asserted-by":"publisher","first-page":"157130","DOI":"10.1016\/j.phymed.2025.157130","volume":"146","author":"H Du","year":"2025","unstructured":"Du H, Luo Y, Zhou N, Wang T, Wang R, Wang Y, Lv C. Capsaicin ameliorates cholestasis through modulation of the fxr-shp and fxr-fgf15 gut-liver axis in mice, Phytomedicine. Int J Phytotherapy Phytopharmacology. 2025;146:157130.","journal-title":"Int J Phytotherapy Phytopharmacology"},{"issue":"1","key":"8648_CR16","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s40168-023-01709-5","volume":"11","author":"H Xu","year":"2023","unstructured":"Xu H, Fang F, Wu K, Song J, Li Y, Lu X, Liu J, Zhou L, Yu W, Yu F, Gao J. Gut microbiota-bile acid crosstalk regulates murine lipid metabolism via the intestinal fxr-fgf19 axis in diet-induced humanized dyslipidemia. Microbiome. 2023;11(1):262.","journal-title":"Microbiome"},{"issue":"8049","key":"8648_CR17","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41586-024-08379-9","volume":"638","author":"TH Won","year":"2025","unstructured":"Won TH, Arifuzzaman M, Parkhurst CN, Miranda IC, Zhang B, Hu E, Kashyap S, Letourneau J, Jin W, Fu Y, Guzior DV, Jri LCB, Quinn RA, Guo C, David LA, Artis D, Schroeder FC. Host metabolism balances microbial regulation of bile acid signalling. Nature. 2025;638(8049):216\u201324.","journal-title":"Nature"},{"issue":"1","key":"8648_CR18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","volume":"24","author":"A Wahlstr","year":"2016","unstructured":"Wahlstr A, Sayin MSI, Marschall H, Ckhed FB. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab. 2016;24(1):41\u201350.","journal-title":"Cell Metab"},{"issue":"3","key":"8648_CR19","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1136\/gutjnl-2015-310283","volume":"66","author":"A Pars\u00e9us","year":"2017","unstructured":"Pars\u00e9us A, Sommer N, Sommer F, Caesar R, Molinaro A, St Hlman M, Greiner TU, Perkins R, Ckhed FB. Microbiota-induced obesity requires farnesoid x receptor. Gut. 2017;66(3):429\u201337.","journal-title":"Gut"},{"key":"8648_CR20","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev-nutr-082018-124344","volume":"39","author":"JYL Chiang","year":"2019","unstructured":"Chiang JYL, Ferrell JM. Bile acids as metabolic regulators and nutrient sensors. Annu Rev Nutr. 2019;39:175\u2013200.","journal-title":"Annu Rev Nutr"},{"issue":"8","key":"8648_CR21","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1016\/j.ajpath.2017.04.019","volume":"187","author":"PK Jena","year":"2017","unstructured":"Jena PK, Sheng L, Liu H, Kalanetra KM, Mirsoian A, Murphy WJ, French SW, Krishnan VV, Mills DA, Wan YY. Western diet-induced dysbiosis in farnesoid x receptor knockout mice causes persistent hepatic inflammation after antibiotic treatment. Am J Pathol. 2017;187(8):1800\u201313.","journal-title":"Am J Pathol"},{"issue":"1","key":"8648_CR22","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1172\/JCI76738","volume":"125","author":"C Jiang","year":"2015","unstructured":"Jiang C, Xie C, Li F, Zhang L, Nichols RG, Krausz KW, Cai J, Qi Y, Fang Z, Takahashi S, Tanaka N, Desai D, Amin SG, Albert I, Patterson AD, Gonzalez FJ. Intestinal farnesoid x receptor signaling promotes nonalcoholic fatty liver disease. J Clin Investig. 2015;125(1):386\u2013402.","journal-title":"J Clin Investig"},{"issue":"7","key":"8648_CR23","doi-asserted-by":"publisher","first-page":"e1006780","DOI":"10.1371\/journal.pgen.1006780","volume":"13","author":"MA El-Brolosy","year":"2017","unstructured":"El-Brolosy MA, Stainier DYR. Genetic compensation: a phenomenon in search of mechanisms. Plos Genet. 2017;13(7):e1006780.","journal-title":"Plos Genet"},{"issue":"1","key":"8648_CR24","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.gendis.2023.02.010","volume":"11","author":"L Zhao","year":"2023","unstructured":"Zhao L, Yang Z, Zheng M, Shi L, Gu M, Liu G, Miao F, Chang Y, Huang F, Tang N. Recombinant adeno-associated virus 8 vector in gene therapy: opportunities and challenges. Genes Dis. 2023;11(1):283\u201393.","journal-title":"Genes Dis"},{"issue":"12","key":"8648_CR25","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1038\/s41587-024-02523-6","volume":"43","author":"J Kim","year":"2025","unstructured":"Kim J, Kurial SNT, Choksi PK, Nunez M, Lunow-Luke T, Bartel J, Driscoll J, Her CL, Dhillon S, Yue W, Murti A, Mao T, Ramos JN, Tiyaboonchai A, Grompe M, Mattis AN, Syed SM, Wang BM, Maher JJ, Roll GR, Willenbring H. Aav capsid prioritization in normal and steatotic human livers maintained by machine perfusion. Nat Biotechnol. 2025;43(12):1966\u201378.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"8648_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13059-023-02852-w","volume":"24","author":"Y Zhan","year":"2023","unstructured":"Zhan Y, Cao C, Li A, Mei H, Liu Y. Enhanced rna knockdown efficiency with engineered fusion guide rnas that function with both crispr-casrx and hammerhead ribozyme. Genome Biol. 2023;24(1):9.","journal-title":"Genome Biol"},{"issue":"3","key":"8648_CR27","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.cell.2018.02.033","volume":"173","author":"S Konermann","year":"2018","unstructured":"Konermann S, Lotfy P, Brideau NJ, Oki J, Shokhirev MN, Hsu PD. Transcriptome engineering with rna-targeting type vi-d crispr effectors. Cell. 2018;173(3):665\u201376.","journal-title":"Cell"},{"key":"8648_CR28","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.molmet.2018.12.004","volume":"20","author":"X Xiong","year":"2019","unstructured":"Xiong X, Wang Q, Wang S, Zhang J, Liu T, Guo L, Yu Y, Lin JD. Mapping the molecular signatures of diet-induced nash and its regulation by the hepatokine tsukushi. Mol Metab. 2019;20:128\u201337.","journal-title":"Mol Metab"},{"issue":"12","key":"8648_CR29","doi-asserted-by":"publisher","first-page":"e115922","DOI":"10.1371\/journal.pone.0115922","volume":"9","author":"W Liang","year":"2014","unstructured":"Liang W, Menke AL, Driessen A, Koek GH, Lindeman JH, Stoop R, Havekes LM, Kleemann R, van den Hoek AM. Establishment of a general nafld scoring system for rodent models and comparison to human liver pathology. PLoS ONE. 2014;9(12):e115922.","journal-title":"PLoS ONE"},{"key":"8648_CR30","doi-asserted-by":"crossref","unstructured":"Bolyen E, Rideout JR, Dillon MR, Bokulich NA, Abnet CC, Al-Ghalith GA, Alexander H, Alm EJ, Arumugam M, Asnicar F, Bai Y, Bisanz JE, Bittinger K, Brejnrod A, Brislawn CJ, Brown CT, Callahan BJ, Caraballo-Rodr\u00edguez AM, Chase J, Cope EK, Da Silva R, Diener C, Dorrestein PC, Douglas GM, Durall DM, Duvallet C, Edwardson CF, Ernst M, Estaki M, Fouquier J, Gauglitz JM, Gibbons SM, Gibson DL, Gonzalez A, Gorlick K, Guo J, Hillmann B, Holmes S, Holste H, Huttenhower C, Huttley GA, Janssen S, Jarmusch AK, Jiang L, Kaehler BD, Kang KB, Keefe CR, Keim P, Kelley ST, Knights D, Koester I, Kosciolek T, Kreps J, Langille MGI, Lee J, Ley R, Liu Y, Loftfield E, Lozupone C, Maher M, Marotz C, Martin BD, Mcdonald D, Mciver LJ, Melnik AV, Metcalf JL, Morgan SC, Morton JT, Naimey AT, Navas-Molina JA, Nothias LF, Orchanian SB, Pearson T, Peoples SL, Petras D, Preuss ML, Pruesse E, Rasmussen LB, Rivers A, Robeson MSN, Rosenthal P, Segata N, Shaffer M, Shiffer A, Sinha R, Song SJ, Spear JR, Swafford AD, Thompson LR, Torres PJ, Trinh P, Tripathi A, Turnbaugh PJ, Ul-Hasan S, van der Hooft JJJ, Vargas F, V\u00e1zquez-Baeza Y, Vogtmann E, von Hippel M, Walters W, Wan Y, Wang M, Warren J, Weber KC, C.H.D., Williamson AD, Willis ZZ, Xu JR, Zaneveld Y, Zhang. Q. Zhu, R. Knight, J.G. Caporaso, Reproducible, interactive, scalable and extensible microbiome data science using qiime 2, Nat Biotechnol 37(8) (2019) 852\u2013857.","DOI":"10.7287\/peerj.preprints.27295v2"},{"issue":"7","key":"8648_CR31","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nmeth.3869","volume":"13","author":"BJ Callahan","year":"2016","unstructured":"Callahan BJ, Mcmurdie PJ, Rosen MJ, Han AW, Johnson AJA, Holmes SP. Dada2: high-resolution sample inference from illumina amplicon data. Nat Methods. 2016;13(7):581\u20133.","journal-title":"Nat Methods"},{"issue":"Database issue","key":"8648_CR32","first-page":"D590","volume":"41","author":"C Quast","year":"2013","unstructured":"Quast C, Pruesse E, Yilmaz P, Gerken J, Schweer T, Yarza P, Peplies JR, Gl Ckner FO. The silva ribosomal rna gene database project: improved data processing and web-based tools. Nucleic Acids Res. 2013;41(Database issue):D590\u20136.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"8648_CR33","doi-asserted-by":"publisher","first-page":"R60","DOI":"10.1186\/gb-2011-12-6-r60","volume":"12","author":"N Segata","year":"2011","unstructured":"Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, Huttenhower C. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12(6):R60.","journal-title":"Genome Biol"},{"issue":"1","key":"8648_CR34","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.1038\/s41467-020-18476-8","volume":"11","author":"VK Gupta","year":"2020","unstructured":"Gupta VK, Kim M, Bakshi U, Cunningham KY, Davis JMR, Lazaridis KN, Nelson H, Chia N, Sung J. A predictive index for health status using species-level gut microbiome profiling. Nat Commun. 2020;11(1):4635.","journal-title":"Nat Commun"},{"issue":"3","key":"8648_CR35","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.chom.2014.02.005","volume":"15","author":"D Gevers","year":"2014","unstructured":"Gevers D, Kugathasan S, Denson LA, V\u00e1zquez-Baeza Y, Van Treuren W, Ren B, Schwager E, Knights D, Song SJ, Yassour M, Morgan XC, Kostic AD, Luo C, Gonz\u00e1lez A, Mcdonald D, Haberman Y, Walters T, Baker S, Rosh J, Stephens M, Heyman M, Markowitz J, Baldassano R, Griffiths A, Sylvester F, Mack D, Kim S, Crandall W, Hyams J, Huttenhower C, Knight R, Xavier RJ. The treatment-naive microbiome in new-onset crohn\u2019s disease. Cell Host Microbe. 2014;15(3):382\u201392.","journal-title":"Cell Host Microbe"},{"issue":"12","key":"8648_CR36","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1038\/s41591-018-0222-4","volume":"24","author":"L Sun","year":"2018","unstructured":"Sun L, Xie C, Wang G, Wu Y, Wu Q, Wang X, Liu J, Deng Y, Xia J, Chen B, Zhang S, Yun C, Lian G, Zhang X, Zhang H, Bisson WH, Shi J, Gao X, Ge P, Liu C, Krausz KW, Nichols RG, Cai J, Rimal B, Patterson AD, Wang X, Gonzalez FJ, Jiang C. Gut microbiota and intestinal fxr mediate the clinical benefits of metformin. Nat Med. 2018;24(12):1919\u201329.","journal-title":"Nat Med"},{"issue":"7","key":"8648_CR37","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41592-020-0866-0","volume":"17","author":"W Yi","year":"2020","unstructured":"Yi W, Li J, Zhu X, Wang X, Fan L, Sun W, Liao L, Zhang J, Li X, Ye J, Chen F, Taipale J, Chan KM, Zhang L, Yan J. Crispr-assisted detection of rna-protein interactions in living cells. Nat Methods. 2020;17(7):685\u20138.","journal-title":"Nat Methods"},{"issue":"20","key":"8648_CR38","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1182\/blood.2024027772","volume":"146","author":"B Li","year":"2025","unstructured":"Li B, Fan H, Wu H, Zhang Y, Ding N, Liu P, Wang Q, Cao M, Meng Z, Feng X, Zhuo X, Wu W, Xiong Y, Deng K, Li T, Liu J, Wu Y. Targeting fxr in hepatocytes: a promising approach to enhance fibrinolysis and reduce deep vein thrombosis risk. Blood. 2025;146(20):2464\u201378.","journal-title":"Blood"},{"issue":"1","key":"8648_CR39","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1136\/gutjnl-2021-324305","volume":"71","author":"M Trauner","year":"2022","unstructured":"Trauner M, Fuchs CD. Novel therapeutic targets for cholestatic and fatty liver disease. Gut. 2022;71(1):194\u2013209.","journal-title":"Gut"},{"issue":"5","key":"8648_CR40","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.jhep.2023.07.034","volume":"79","author":"L Adorini","year":"2023","unstructured":"Adorini L, Trauner M. Fxr agonists in nash treatment. J Hepatol. 2023;79(5):1317\u201331.","journal-title":"J Hepatol"},{"issue":"8","key":"8648_CR41","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/j.cmet.2021.06.012","volume":"33","author":"BL Clifford","year":"2021","unstructured":"Clifford BL, Sedgeman LR, Williams KJ, Morand P, Cheng A, Jarrett KE, Chan AP, Brearley-Sholto MC, Wahlstr A, Ashby MJW, Barshop W, Wohlschlegel J, Calkin AC, Liu Y, Thorell A, Meikle PJ, Drew BG, Mack JJ, Marschall H, Tarling EJ, Edwards PA. de Aguiar Vallim, Fxr activation protects against nafld via bile-acid-dependent reductions in lipid absorption. Cell Metab. 2021;33(8):1671\u201384.","journal-title":"Cell Metab"},{"key":"8648_CR42","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.jare.2024.12.016","volume":"76","author":"Z Ma","year":"2025","unstructured":"Ma Z, Qiu Y, Yu Z, Song T, Hu Y, Peng A, Qi R. Natural small molecule hinokitone mitigates nash fibrosis by targeting regulation of fxr-mediated hepatocyte apoptosis. J Adv Res. 2025;76:553\u201368.","journal-title":"J Adv Res"},{"issue":"1","key":"8648_CR43","doi-asserted-by":"publisher","first-page":"2496437","DOI":"10.1080\/19490976.2025.2496437","volume":"17","author":"Z Luo","year":"2025","unstructured":"Luo Z, Huang Y, Yong K, Wu D, Zheng L, Yao X, Shen L, Yu S, Wang B, Cao S. Gut microbiota regulates hepatic ketogenesis and lipid accumulation in ketogenic diet-induced hyperketonemia by disrupting bile acid metabolism. Gut Microbes. 2025;17(1):2496437.","journal-title":"Gut Microbes"},{"issue":"7","key":"8648_CR44","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of nafld development and therapeutic strategies. Nat Med. 2018;24(7):908\u201322.","journal-title":"Nat Med"},{"issue":"1","key":"8648_CR45","doi-asserted-by":"publisher","first-page":"1949095","DOI":"10.1080\/19490976.2021.1949095","volume":"13","author":"J Xiang","year":"2021","unstructured":"Xiang J, Zhang Z, Xie H, Zhang C, Bai Y, Cao H, Che Q, Guo J, Su Z. Effect of different bile acids on the intestine through enterohepatic circulation based on fxr. Gut Microbes. 2021;13(1):1949095.","journal-title":"Gut Microbes"},{"issue":"5","key":"8648_CR46","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.jhep.2025.06.010","volume":"83","author":"U Beuers","year":"2025","unstructured":"Beuers U, Banales JM, Karpen SJ, Keitel V, Williamson C, Trauner M. The history and future of bile acid therapies. J Hepatol. 2025;83(5):1172\u201388.","journal-title":"J Hepatol"},{"issue":"7","key":"8648_CR47","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1053\/j.gastro.2017.01.055","volume":"152","author":"O Ch\u00e1vez-Talavera","year":"2017","unstructured":"Ch\u00e1vez-Talavera O, Tailleux A, Lefebvre P, Staels B. Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease. Gastroenterology. 2017;152(7):1679\u201394.","journal-title":"Gastroenterology"},{"issue":"11","key":"8648_CR48","doi-asserted-by":"publisher","first-page":"4858","DOI":"10.1016\/j.apsb.2024.08.021","volume":"14","author":"S Na","year":"2024","unstructured":"Na S, Fan Y, Chen H, Li L, Li G, Zhang F, Wang R, Yang Y, Shen Z, Peng Z, Wu Y, Zhu Y, Yang Z, Dong G, Ye Q, Yue J. Ppar\u03b1 affects hepatic lipid homeostasis by perturbing necroptosis signals in the intestinal epithelium. Acta Pharm Sinica B. 2024;14(11):4858\u201373.","journal-title":"Acta Pharm Sinica B"},{"key":"8648_CR49","doi-asserted-by":"publisher","first-page":"116912","DOI":"10.1016\/j.ecoenv.2024.116912","volume":"284","author":"L Lei","year":"2024","unstructured":"Lei L, Deng D, Xu W, Yue M, Wu D, Fu K, Shi Z. Increased intestinal permeability and lipopolysaccharide contribute to swainsonine-induced systemic inflammation. Ecotoxicol Environ Saf. 2024;284:116912.","journal-title":"Ecotoxicol Environ Saf"},{"key":"8648_CR50","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.jare.2024.01.019","volume":"67","author":"J Li","year":"2025","unstructured":"Li J, Guo C, Liu Y, Han B, Lv Z, Jiang H, Li S, Zhang Z. Chronic arsenic exposure-provoked biotoxicity involved in liver-microbiota-gut axis disruption in chickens based on multi-omics technologies. J Adv Res. 2025;67:373\u201386.","journal-title":"J Adv Res"},{"issue":"4","key":"8648_CR51","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1136\/gut.2010.212159","volume":"60","author":"RM Gadaleta","year":"2011","unstructured":"Gadaleta RM, van Erpecum KJ, Oldenburg B, Willemsen ECL, Renooij W, Murzilli S, Klomp LWJ, Siersema PD, Schipper MEI, Danese S, Penna G, Laverny G, Adorini L, Moschetta A, van Mil SWC. Farnesoid x receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease. Gut. 2011;60(4):463\u201372.","journal-title":"Gut"},{"issue":"5","key":"8648_CR52","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.jhep.2020.05.007","volume":"73","author":"J Gulfo","year":"2020","unstructured":"Gulfo J, Rotondo F, \u00e1valos De CG, Le\u00f3n ME, Cornide-Petronio C, Fuster J, Gracia-Sancho MB, Jim\u00e9nez-Castro C, Peralta. Fgf15 improves outcomes after brain dead donor liver transplantation with steatotic and non-steatotic grafts in rats. J Hepatol. 2020;73(5):1131\u201343.","journal-title":"J Hepatol"},{"issue":"6","key":"8648_CR53","first-page":"2150","volume":"67","author":"P Hartmann","year":"2018","unstructured":"Hartmann P, Hochrath K, Horvath A, Chen P, Seebauer CT, Llorente C, Wang L, Alnouti Y, Fouts DE, St Rkel P, Loomba R, Coulter S, Liddle C, Yu RT, Ling L, Rossi SJ, Depaoli AM, Downes M, Evans RM, Brenner DA, Schnabl B. Modulation of the intestinal bile acid\/farnesoid x receptor\/fibroblast growth factor 15 axis improves alcoholic liver disease in mice, Hepatology (Baltimore. Md). 2018;67(6):2150\u201366.","journal-title":"Md)"},{"issue":"1","key":"8648_CR54","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41467-023-35861-1","volume":"14","author":"M Yang","year":"2023","unstructured":"Yang M, Qi X, Li N, Kaifi JT, Chen S, Wheeler AA, Kimchi ET, Ericsson AC, Rector RS, Staveley-O\u2019Carroll KF, Li G. Western diet contributes to the pathogenesis of non-alcoholic steatohepatitis in male mice via remodeling gut microbiota and increasing production of 2-oleoylglycerol. Nat Commun. 2023;14(1):228.","journal-title":"Nat Commun"},{"issue":"1","key":"8648_CR55","doi-asserted-by":"publisher","first-page":"2612580","DOI":"10.1080\/19490976.2025.2612580","volume":"18","author":"P Paone","year":"2026","unstructured":"Paone P, Petitfils C, Puel A, Latousakis D, de Vos WM, Delzenne NM, Juge N, Van Hul M, Cani PD. Akkermansia muciniphila modulates intestinal mucus composition to counteract high-fat diet-induced obesity in mice. Gut Microbes. 2026;18(1):2612580.","journal-title":"Gut Microbes"},{"issue":"1","key":"8648_CR56","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.cmet.2024.09.008","volume":"37","author":"L Song","year":"2025","unstructured":"Song L, Hou Y, Xu D, Dai X, Luo J, Liu Y, Huang Z, Yang M, Chen J, Hu Y, Chen C, Tang Y, Rao Z, Ma J, Zheng M, Shi K, Cai C, Lu M, Tang R, Ma X, Xie C, Luo Y, Li X, Huang Z. Hepatic fxr-fgf4 is required for bile acid homeostasis via an fgfr4-lrh-1 signal node under cholestatic stress. Cell Metab. 2025;37(1):104\u201320.","journal-title":"Cell Metab"},{"issue":"6","key":"8648_CR57","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1002\/hep.32577","volume":"76","author":"W Xu","year":"2022","unstructured":"Xu W, Cui C, Cui C, Chen Z, Zhang H, Cui Q, Xu G, Fan J, Han Y, Tang L, Targher G, Byrne CD, Zheng M, Yang L, Cai J, Geng B. Hepatocellular cystathionine \u03b3 lyase\/hydrogen sulfide attenuates nonalcoholic fatty liver disease by activating farnesoid x receptor. Hepatology (Baltimore MD). 2022;76(6):1794\u2013810.","journal-title":"Hepatology (Baltimore MD)"},{"issue":"3","key":"8648_CR58","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/s41401-024-01412-7","volume":"46","author":"Y Liu","year":"2025","unstructured":"Liu Y, Luo R, Liu A, Wang J, Hu N, Li W, Li J, Wang J, Duan J. Identification of chikusetsusaponin iva as a novel lysine-specific demethylase 1 inhibitor that ameliorates high fat diet-induced masld in mice. Acta Pharmacol Sin. 2025;46(3):632\u201352.","journal-title":"Acta Pharmacol Sin"},{"issue":"9972","key":"8648_CR59","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","volume":"385","author":"BA Neuschwander-Tetri","year":"2015","unstructured":"Neuschwander-Tetri BA, Loomba R, Sanyal AJ, Lavine JE, Van Natta ML, Abdelmalek MF, Chalasani N, Dasarathy S, Diehl AM, Hameed B, Kowdley KV, Mccullough A, Terrault N, Clark JM, Tonascia J, Brunt EM, Kleiner DE, Doo E, Nash CRN. Farnesoid x nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (flint): a multicentre, randomised, placebo-controlled trial. Lancet (London England). 2015;385(9972):956\u201365.","journal-title":"Lancet (London England)"},{"key":"8648_CR60","doi-asserted-by":"crossref","unstructured":"Moon A, Briand FO, Breyner N, Song D, Madsen MRN, Kim H, Choi K, Lee Y, Namkung W. Improvement of nash and liver fibrosis through modulation of the gut-liver axis by a novel intestinal fxr agonist. Volume 173. Biomedicine & Pharmacotherapy\u2009=\u2009Biomedecine & Pharmacotherapie; 2024. p. 116331.","DOI":"10.1016\/j.biopha.2024.116331"},{"key":"8648_CR61","doi-asserted-by":"publisher","first-page":"101094","DOI":"10.1016\/j.plipres.2021.101094","volume":"82","author":"S Fiorucci","year":"2021","unstructured":"Fiorucci S, Distrutti E, Carino A, Zampella A, Biagioli M. Bile acids and their receptors in metabolic disorders. Prog Lipid Res. 2021;82:101094.","journal-title":"Prog Lipid Res"},{"issue":"1","key":"8648_CR62","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/s41392-023-01673-4","volume":"8","author":"M Yan","year":"2023","unstructured":"Yan M, Man S, Sun B, Ma L, Guo L, Huang L, Gao W. Gut liver brain axis in diseases: the implications for therapeutic interventions. Signal Transduct Target Ther. 2023;8(1):443.","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"8648_CR63","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1194\/jlr.M071183","volume":"57","author":"S Takahashi","year":"2016","unstructured":"Takahashi S, Fukami T, Masuo Y, Brocker CN, Xie C, Krausz KW, Wolf CR, Henderson CJ, Gonzalez FJ. Cyp2c70 is responsible for the species difference in bile acid metabolism between mice and humans. J Lipid Res. 2016;57(12):2130\u20137.","journal-title":"J Lipid Res"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08648-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08648-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08648-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:02:53Z","timestamp":1791504173000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08648-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8648"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08648-3","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"assertion":[{"value":"8 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1269"}}